The Promise & Peril of Personalized Oncology Tuesday, August 25th

(click here to listen to the webcast)

 Email your questions to: patientpower@vanderbilt.edu

	Dr. Jeffery Sosman Professor of Medicine, Hematology/Oncology More information on Dr. Jeffery Sosman here
	Dr. William Pao Ingram Associate Professor of Cancer Research Assistant Director, Personalized Cancer Medicine Vanderbilt-Ingram Cancer Center More information on Dr. William Pao here

About the Webcast
Click HERE to listen to the webcast.

Everybody’s talking about personalized medicine ... What’s the real promise here and what might be hype?  Personalized medicine in cancer includes the use of genetic testing to determine the molecular makeup of a tumor. It also addresses other important issues, like cancer is not just one disease, or even dozens of diseases based on location in the body.  ‘Breast cancer’ and ‘lung cancer’ are both comprised of many different diseases, and many respond to different therapies.  All of this enables physicians to match the patient with the best treatment, sparing patients from undergoing treatments that may not work for them. 

Please join Dr. Jeffrey Sosman, Professor of Medicine in Hematology/Oncology and Dr. William Pao, Assistant Director, Personalized Cancer Medicine at Vanderbilt-Ingram Cancer Center on Tuesday, August 25th, to learn more about this topic.  The webcast will broadcast live at 6:00pm and listeners will be encouraged to call or email their questions in during the show.